M&T Bank Corp boosted its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 76.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 24,552 shares of the semiconductor company's stock after acquiring an additional 10,612 shares during the period. M&T Bank Corp's holdings in Synopsys were worth $11,533,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Caliber Wealth Management LLC KS boosted its holdings in shares of Synopsys by 4.3% in the 4th quarter. Caliber Wealth Management LLC KS now owns 3,161 shares of the semiconductor company's stock valued at $1,485,000 after buying an additional 131 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. boosted its holdings in shares of Synopsys by 9.0% in the 4th quarter. Migdal Insurance & Financial Holdings Ltd. now owns 511 shares of the semiconductor company's stock valued at $240,000 after buying an additional 42 shares in the last quarter. Salomon & Ludwin LLC boosted its holdings in shares of Synopsys by 97.7% in the 4th quarter. Salomon & Ludwin LLC now owns 87 shares of the semiconductor company's stock valued at $43,000 after buying an additional 43 shares in the last quarter. GraniteShares Advisors LLC boosted its holdings in shares of Synopsys by 28.2% in the 4th quarter. GraniteShares Advisors LLC now owns 2,519 shares of the semiconductor company's stock valued at $1,183,000 after buying an additional 554 shares in the last quarter. Finally, Legacy Advisors LLC boosted its holdings in shares of Synopsys by 4.4% in the 4th quarter. Legacy Advisors LLC now owns 1,533 shares of the semiconductor company's stock valued at $720,000 after buying an additional 65 shares in the last quarter. 85.47% of the stock is currently owned by institutional investors.
Synopsys Stock Performance
SNPS opened at $500.82 on Friday. Synopsys, Inc. has a 12-month low of $376.18 and a 12-month high of $651.73. The company has a current ratio of 1.36, a quick ratio of 1.26 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $95.94 billion, a PE ratio of 77.77, a P/E/G ratio of 3.73 and a beta of 1.15. The firm has a 50 day moving average of $426.02 and a two-hundred day moving average of $445.33.
Synopsys (NASDAQ:SNPS - Get Free Report) last posted its quarterly earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.56 by $0.21. Synopsys had a net margin of 13.76% and a return on equity of 6.83%. The company had revenue of $2.41 billion during the quarter, compared to analyst estimates of $2.39 billion. During the same period last year, the firm posted $3.03 EPS. Synopsys's revenue for the quarter was up 65.6% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. On average, analysts anticipate that Synopsys, Inc. will post 10.3 EPS for the current year.
Analyst Upgrades and Downgrades
SNPS has been the topic of a number of recent analyst reports. Morgan Stanley restated an "equal weight" rating and issued a $480.00 price target (down from $550.00) on shares of Synopsys in a report on Wednesday, February 25th. Wells Fargo & Company lowered their price target on shares of Synopsys from $500.00 to $450.00 and set an "equal weight" rating on the stock in a report on Thursday, February 26th. HSBC cut shares of Synopsys from a "buy" rating to a "hold" rating and set a $455.00 price target on the stock. in a report on Friday, February 20th. Weiss Ratings restated a "hold (c)" rating on shares of Synopsys in a report on Thursday, January 22nd. Finally, Piper Sandler lowered their price target on shares of Synopsys from $520.00 to $430.00 and set a "neutral" rating on the stock in a report on Thursday, February 26th. Eight research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, Synopsys currently has an average rating of "Hold" and an average price target of $531.00.
Check Out Our Latest Stock Report on Synopsys
Synopsys Profile
(
Free Report)
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Stories
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.